Cardiovascular Disease
CVD, not drug overdoses, may explain stagnation in US life expectancy
Should the term ‘metabolic syndrome’ be changed to ‘circadian syndrome’?
The underlying etiology of the metabolic syndrome, a cardiometabolic risk factor cluster — central obesity, low HDL cholesterol, impaired glucose tolerance, elevated triglycerides and hypertension — remains the subject of debate. Gerald Reaven, MD, the Stanford University researcher who coined the syndrome’s original name of “syndrome X,” suggested insulin resistance was the cause, but this is only partly correct. Insulin resistance is just one of the outcomes of circadian dysfunction, along with the above risk factors.
Study highlights need for increased awareness of cardiovascular risk in transgender women
Eating breakfast may protect against CVD, plus more top stories in endocrinology
Rheumatologists or primary care: Who bears 'responsibility' for CV risk?
FDA draft guidance eliminates CV outcomes trial recommendation for diabetes drug approvals
Family MI history raises mortality risk in women undergoing bilateral oophorectomy
Women aged 45 years or younger who undergo bilateral oophorectomy and report having a first-degree relative who experienced premature myocardial infarction are at greater risk for cardiovascular death or death from any cause when compared with women without either condition, according to findings published in Menopause.
Estradiol slows lipid progression in early menopause
Women in early menopause who received oral estradiol treatment had a reduced progression of lipid deposition in the carotid arterial wall compared with placebo, according to a secondary analysis of the ELITE trial presented at the American Heart Association Epidemiology, Prevention, Lifestyle and Cardiometabolic Health Scientific Sessions.